Suppr超能文献

长期扩增的小鼠和人诱导的肾祖细胞可使肾类器官成熟,并对可塑性和疾病进行建模。

Long-term expandable mouse and human-induced nephron progenitor cells enable kidney organoid maturation and modeling of plasticity and disease.

机构信息

USC/UKRO Kidney Research Center, Division of Nephrology and Hypertension, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA; Department of Stem Cell Biology and Regenerative Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.

Department of Stem Cell Biology and Regenerative Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.

出版信息

Cell Stem Cell. 2024 Jun 6;31(6):921-939.e17. doi: 10.1016/j.stem.2024.04.002. Epub 2024 Apr 30.

Abstract

Nephron progenitor cells (NPCs) self-renew and differentiate into nephrons, the functional units of the kidney. Here, manipulation of p38 and YAP activity allowed for long-term clonal expansion of primary mouse and human NPCs and induced NPCs (iNPCs) from human pluripotent stem cells (hPSCs). Molecular analyses demonstrated that cultured iNPCs closely resemble primary human NPCs. iNPCs generated nephron organoids with minimal off-target cell types and enhanced maturation of podocytes relative to published human kidney organoid protocols. Surprisingly, the NPC culture medium uncovered plasticity in human podocyte programs, enabling podocyte reprogramming to an NPC-like state. Scalability and ease of genome editing facilitated genome-wide CRISPR screening in NPC culture, uncovering genes associated with kidney development and disease. Further, NPC-directed modeling of autosomal-dominant polycystic kidney disease (ADPKD) identified a small-molecule inhibitor of cystogenesis. These findings highlight a broad application for the reported iNPC platform in the study of kidney development, disease, plasticity, and regeneration.

摘要

肾祖细胞 (NPCs) 自我更新并分化为肾单位,即肾脏的功能单位。在这里,p38 和 YAP 活性的操纵允许原代小鼠和人类 NPC 的长期克隆扩增,并从人类多能干细胞 (hPSCs) 诱导 NPC (iNPCs)。分子分析表明,培养的 iNPCs 与原代人类 NPC 非常相似。iNPCs 生成的肾单位类器官具有最小的非靶细胞类型,与已发表的人类肾脏类器官方案相比,足细胞的成熟度更高。令人惊讶的是,NPC 培养基揭示了人类足细胞程序的可塑性,使足细胞重编程为 NPC 样状态。可扩展性和基因组编辑的易用性促进了 NPC 培养中的全基因组 CRISPR 筛选,揭示了与肾脏发育和疾病相关的基因。此外,NPC 定向的常染色体显性多囊肾病 (ADPKD) 模型确定了一种囊泡生成的小分子抑制剂。这些发现突出了所报道的 iNPC 平台在肾脏发育、疾病、可塑性和再生研究中的广泛应用。

相似文献

1
Long-term expandable mouse and human-induced nephron progenitor cells enable kidney organoid maturation and modeling of plasticity and disease.
Cell Stem Cell. 2024 Jun 6;31(6):921-939.e17. doi: 10.1016/j.stem.2024.04.002. Epub 2024 Apr 30.
3
Manipulation of Nephron-Patterning Signals Enables Selective Induction of Podocytes from Human Pluripotent Stem Cells.
J Am Soc Nephrol. 2019 Feb;30(2):304-321. doi: 10.1681/ASN.2018070747. Epub 2019 Jan 11.
4
Nephron organoids derived from human pluripotent stem cells model kidney development and injury.
Nat Biotechnol. 2015 Nov;33(11):1193-200. doi: 10.1038/nbt.3392.
5
Generation of nephron progenitor cells and kidney organoids from human pluripotent stem cells.
Nat Protoc. 2017 Jan;12(1):195-207. doi: 10.1038/nprot.2016.170. Epub 2016 Dec 22.
6
-Dependent Renal Cystogenesis in Human Induced Pluripotent Stem Cell-Derived Ureteric Bud/Collecting Duct Organoids.
J Am Soc Nephrol. 2020 Oct;31(10):2355-2371. doi: 10.1681/ASN.2020030378. Epub 2020 Aug 3.
9
Differentiation of human pluripotent stem cells into nephron progenitor cells in a serum and feeder free system.
PLoS One. 2014 Apr 11;9(4):e94888. doi: 10.1371/journal.pone.0094888. eCollection 2014.
10
Nephron progenitor cell commitment: Striking the right balance.
Semin Cell Dev Biol. 2019 Jul;91:94-103. doi: 10.1016/j.semcdb.2018.07.017. Epub 2018 Jul 30.

引用本文的文献

3
Axial nephron fate switching demonstrates a plastic system tunable on demand.
Nat Commun. 2025 Aug 25;16(1):7912. doi: 10.1038/s41467-025-63290-9.
4
Autosomal Dominant Polycystic Kidney Disease: From Pathogenesis to Organoid Disease Models.
Biomedicines. 2025 Jul 18;13(7):1766. doi: 10.3390/biomedicines13071766.
6
Strategies to overcome the limitations of current organoid technology - engineered organoids.
J Tissue Eng. 2025 Apr 15;16:20417314251319475. doi: 10.1177/20417314251319475. eCollection 2025 Jan-Dec.
7
Gene Editing: An Effective Tool for the Future Treatment of Kidney Disease.
J Inflamm Res. 2025 Mar 17;18:4001-4018. doi: 10.2147/JIR.S506760. eCollection 2025.
9
Physiologic mechanisms underlying polycystic kidney disease.
Physiol Rev. 2025 Jul 1;105(3):1553-1607. doi: 10.1152/physrev.00018.2024. Epub 2025 Feb 12.
10
Absent, Small, or Homeotic 2-Like-Mediated H3K4 Methylation and Nephrogenesis.
J Am Soc Nephrol. 2025 May 1;36(5):798-811. doi: 10.1681/ASN.0000000600. Epub 2025 Jan 7.

本文引用的文献

1
A single-cell multiomic analysis of kidney organoid differentiation.
Proc Natl Acad Sci U S A. 2023 May 16;120(20):e2219699120. doi: 10.1073/pnas.2219699120. Epub 2023 May 8.
4
Vasculogenesis in kidney organoids upon transplantation.
NPJ Regen Med. 2022 Aug 19;7(1):40. doi: 10.1038/s41536-022-00237-4.
5
Principles of human and mouse nephron development.
Nat Rev Nephrol. 2022 Oct;18(10):628-642. doi: 10.1038/s41581-022-00598-5. Epub 2022 Jul 22.
7
Cross talk between lysine methyltransferase Smyd2 and TGF-β-Smad3 signaling promotes renal fibrosis in autosomal dominant polycystic kidney disease.
Am J Physiol Renal Physiol. 2022 Aug 1;323(2):F227-F242. doi: 10.1152/ajprenal.00452.2021. Epub 2022 Jun 27.
8
Metformin improves relevant disease parameters in an autosomal dominant polycystic kidney disease mouse model.
Am J Physiol Renal Physiol. 2022 Jan 1;322(1):F27-F41. doi: 10.1152/ajprenal.00298.2021. Epub 2021 Nov 22.
9
A selective WDR5 degrader inhibits acute myeloid leukemia in patient-derived mouse models.
Sci Transl Med. 2021 Sep 29;13(613):eabj1578. doi: 10.1126/scitranslmed.abj1578.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验